prescription drugs
Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds.
new and noteworthy
Women's Health survey

KFF 2026 Women’s Health Survey
For more than two decades, the KFF Women’s Health Survey has provided a nationally representative look at women’s experiences with health care in the United States. Explore the latest findings →
Women’s Health Care Affordability Challenges
As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts in spending on basic needs.
featured videos
Are Health Insurers to Blame for Our Health System Problems?
Political leaders on both sides point fingers at health insurers for high costs and patient frustrations. How much blame do insurers, in fact, deserve for our health system’s problems? This three-part video series from KFF considers this question and the complicated answer, exploring what’s driving rising insurance premiums, whether insurers provide value, and who we trust to decide what gets covered and at what price. Watch and share →
Subscribe to KFF Emails
Choose which emails are best for you.
Sign up here